SPDR系列信託 - State Street SPDR標普生物科技ETF
US ˙ ARCA ˙ US78464A8707

SecurityXBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
InstitutionWP Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
WP Advisors, LLC closes position in XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF

On August 8, 2025 - WP Advisors, LLC filed a 13F-HR form disclosing ownership of 0 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF (US:XBI) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 12, 2025 disclosing 2,613 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-08 2025-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 0 -100.00 0
2025-05-12 2025-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 2,613 0 0.00 212 -10.21 0.0705
2025-02-03 2024-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 2,613 -479 -15.49 235 -22.95 0.0784
2024-11-07 2024-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 3,092 -10,452 -77.17 305 -75.70 0.1116
2024-07-30 2024-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 13,544 -2,927 -17.77 1,256 -19.65 0.4010
2024-05-08 2024-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 16,471 -284 -1.70 1,563 4.41 0.5127
2024-01-31 2023-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 16,755 4,068 32.06 1,496 61.56 0.5538
2023-10-30 2023-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 12,687 303 2.45 926 -10.10 0.3830
2023-07-26 2023-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 12,384 -20 -0.16 1,030 8.99 0.4123
2023-04-14 2023-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 12,404 -1,612 -11.50 945 -18.74 0.3899
2023-01-20 2022-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 14,016 -5,625 -28.64 1,163 -25.35 0.5201
2022-10-24 2022-09-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 19,641 0 0.00 1,558 6.79 0.7055
2022-07-12 2022-06-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 19,641 986 5.29 1,459 -13.00 0.6342
2022-04-25 2022-03-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 18,655 6,380 51.98 1,677 22.05 0.6907
2022-02-02 2021-12-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 12,275 -1,376 -10.08 1,374 -19.93 0.5724
2021-10-20 2021-09-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 13,651 9,357 217.91 1,716 195.35 0.7037
2021-07-22 2021-06-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 4,294 0 0.00 581 -0.34 0.2422
2021-05-06 2021-03-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 4,294 -2,472 -36.54 583 -38.82 0.2519
2021-01-27 2020-12-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 6,766 8 0.12 953 26.56 0.4602
2020-10-16 2020-09-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 6,758 5 0.07 753 -0.40 0.4538
2020-08-07 2020-06-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 6,753 1 0.01 756 44.55 0.5316
2020-04-29 2020-03-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 6,752 0 0.00 523 -18.54 0.5080
2020-01-22 2019-12-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 6,752 154 2.33 642 27.63 0.6628
2019-10-22 2019-09-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 6,598 786 13.52 503 -1.37 0.5765
2019-07-23 2019-06-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 5,812 4,512 347.08 510 -56.67 0.5686
2019-04-15 2019-03-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 1,300 1,300 1,177 0.1281
2019-01-17 2018-12-31 13F SPDR S&P Biotech S&P BIOTECH 78464A870 0 -1,300 -100.00 0 -100.00
2018-10-31 2018-09-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 1,300 -100 -7.14 125 -6.02 0.1164
2018-07-26 2018-06-30 13F SPDR S&P Biotech S&P BIOTECH 78464A870 1,400 1,400 133 0.1255
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.